当前位置:首页 - 行情中心 - 普洛药业(000739) - 财务分析 - 现金流量表

普洛药业

(000739)

  

流通市值:248.73亿  总市值:248.83亿
流通股本:11.58亿   总股本:11.58亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金5,173,664,918.543,336,128,726.071,737,971,817.287,904,152,454.14
  收到的税费返还217,268,747.01142,083,454.3699,466,050.03369,467,740.48
  收到其他与经营活动有关的现金153,714,742.3894,323,238.6538,124,665.53270,785,586.97
  经营活动现金流入小计5,544,648,407.933,572,535,419.081,875,562,532.848,544,405,781.59
  购买商品、接受劳务支付的现金3,156,491,489.752,240,334,034.161,028,481,894.45,147,723,410.54
  支付给职工以及为职工支付的现金786,905,813.66572,284,698.26350,619,906.11986,577,353.54
  支付的各项税费430,154,616.06355,903,155.01215,422,531.49481,977,236.19
  支付其他与经营活动有关的现金496,175,747.18329,684,032.25156,065,558.57707,926,500.57
  经营活动现金流出小计4,869,727,666.653,498,205,919.681,750,589,890.577,324,204,500.84
  经营活动产生的现金流量净额674,920,741.2874,329,499.4124,972,642.271,220,201,280.75
二、投资活动产生的现金流量:
  收回投资收到的现金1,291,656,575.131,028,843,418.761,057,022,526.721,238,929,600.55
  取得投资收益收到的现金---10,468,676.89
  处置固定资产、无形资产和其他长期资产收回的现金净额467,000460,000-33,027,522.95
  处置子公司及其他营业单位收到的现金净额---30,177,588.02
  收到的其他与投资活动有关的现金2,894,031.1883,444.5-266,572.74
  投资活动现金流入小计1,295,017,606.231,030,186,863.261,057,022,526.721,312,869,961.15
  购建固定资产、无形资产和其他长期资产支付的现金275,464,115.12229,053,008.05109,428,231.2386,214,539.82
  投资支付的现金1,320,787,344.761,047,225,548.561,062,111,4001,298,545,500
  支付其他与投资活动有关的现金2,672,280.71705,816.8-427,910.98
  投资活动现金流出小计1,598,923,740.591,276,984,373.411,171,539,631.21,685,187,950.8
  投资活动产生的现金流量净额-303,906,134.36-246,797,510.15-114,517,104.48-372,317,989.65
三、筹资活动产生的现金流量:
  吸收投资收到的现金3,832,702.5---
  取得借款收到的现金1,156,000,000720,000,000240,000,0002,134,900,000
  收到其他与筹资活动有关的现金81,968,70028,068,700--
  筹资活动现金流入小计1,241,801,402.5748,068,700240,000,0002,134,900,000
  偿还债务支付的现金1,208,068,700712,000,000188,000,0001,416,000,000
  分配股利、利润或偿付利息支付的现金364,513,975.29285,944,475.038,957,136.08836,106,817.82
  支付其他与筹资活动有关的现金168,791,424.8767,659,879.9729,336,574.67525,879,626.33
  筹资活动现金流出小计1,741,374,100.161,065,604,355226,293,710.752,777,986,444.15
  筹资活动产生的现金流量净额-499,572,697.66-317,535,65513,706,289.25-643,086,444.15
四、汇率变动对现金及现金等价物的影响-39,433,357.78-30,480,895.92-16,375,254.92-9,951,342.78
五、现金及现金等价物净增加额-167,991,448.52-520,484,561.677,786,572.12194,845,504.17
  加:期初现金及现金等价物余额2,924,290,064.232,924,290,064.232,924,290,064.232,729,444,560.06
  期末现金及现金等价物余额2,756,298,615.712,403,805,502.562,932,076,636.352,924,290,064.23
补充资料:
  净利润-522,563,447.12-890,681,701.93
  资产减值准备-48,488,025.78-83,431,190.26
  固定资产和投资性房地产折旧-328,411,779.97-652,302,409.38
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-328,411,779.97-652,302,409.38
  无形资产摊销-5,312,395.04-10,082,544.47
  长期待摊费用摊销-5,234,153.2-9,085,712.96
  处置固定资产、无形资产和其他长期资产的损失--136,291.96--9,032,000.65
  固定资产报废损失-392,722.78-1,686,363.84
  公允价值变动损失--7,637,055.28--
  财务费用-40,325,181.4-34,354,081.4
  投资损失--7,890,026.96--30,194,921.98
  递延所得税-618,602.12--24,321,718.92
  其中:递延所得税资产减少-6,993,290.74--7,038,549.9
    递延所得税负债增加--6,374,688.62--17,283,169.02
  存货的减少--27,012,695.1-165,584,111.48
  经营性应收项目的减少--624,023,805.59--227,868,060.56
  经营性应付项目的增加--214,033,555.36--342,738,844.61
  其他---525,492.83
  现金的期末余额-2,403,805,502.56-2,924,290,064.23
  减:现金的期初余额-2,924,290,064.23-2,729,444,560.06
  现金及现金等价物的净增加额--520,484,561.67-194,845,504.17
公告日期2026-10-232026-08-202026-04-212026-03-20
审计意见(境内)标准无保留意见
TOP↑